ECC or Margins Positive?

Size: px
Start display at page:

Download "ECC or Margins Positive?"

Transcription

1 CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson, including the INITIAL EVALUATION STAGING Yes PRIMARY TREATMENT Repeat Cone Reassign stage based on histologic margins Stage IA 1 2 ECC or Margins Positive? No Observation OR Simple Hysterectomy 5 Surveillance: See Page 4 Non-visible Lesion Cone Biopsy with ECC 1 Stage IA 2 Radical Hysterectomy and Pelvic Lymph Node Dissection OR Radical Trachelectomy and Pelvic Lymph Node Dissection OR Radiation Therapy High Risk Factors 3 Intermediate Risk Factors 4 Chemoradiotherapy 5 Radiotherapy or Chemoradiotherapy 5 1 ECC= Endocervical Cutterage 2 Consider radical hysterectomy for patients with Stage IA1 cancer with LVSI and/or grade 3 adenocarcinoma 3 High risk factors are positive nodes, positive margins, or parametrial involvement. 4 Intermediate risk factors (see Sedlis A. et al.) 5 Concurrent weekly Cisplatin Low Risk Factors

2 CLINICAL PRESENTATION STAGING Stage IB1 PRIMARY TREATMENT Radical Hysterectomy and Pelvic Node Dissection OR Radical Trachelectomy and Pelvic Lymph Node Dissection OR Radiation Therapy 1 High Risk Factors 3 Chemoradiation 5 Intermediate Risk Factors 4 5 Chemoradiation OR Radiation Therapy Low Risk Factors Surveillance Visible Lesion Chest X-ray Renal/Liver Function Testing Optional pelvic imaging Stage IB2 Stage IIA Stage IIB Stage IIIA/B Stage IVA Chemoradiation 2 Surveillance: See Page 4 Stage IVB Chemotherapy OR Palliative Treatment OR Supportive Care 1 Relative indications in favor of Primary Radiation Therapy are : + Nodes, extensive LVSI, deep stromal invasion. 2 Consider extraperitoneal surgical staging 3 High risk factors are positive nodes, positive margins, or parametrial involvement. 4 Intermediate risk factors (see Sedlis A. et al.) 5 Concurrent weekly Cisplatin

3 RECURRANCE TREATMENT No Prior Radiotherapy ChemoRadiation 1 Pelvic Recurrence Recurrence in Central Pelvis Pelvic Exenteration, OR Chemotherapy Prior Radiotherapy Isolated Extrapelvic Recurrence Surgical Resection, OR Radiotherapy, OR Chemotherapy OR Combined Modality Individualized follow-up based on clinical indications and treatment plan Multiple sites of metastatic disease Chemotherapy OR Supportive Care OR Palliative Treatment 1 Weekly Cisplatin

4 Surveillance: Interval H&P Cervical /vaginal cytology every 3-6 months for 2 years then, then very 6 months until 5 years then annually Chest X-ray annually (optional) CBC, BUN, Creatinine every 6 months (optional) Imaging as clinically indicated Recommended use of vaginal dilator after radiation treatment

5 SUGGESTED READINGS 1. National Comprehensive Cancer Network. (2010). Cervical Cancer Guidelines. Retrieved January 30, 2010,from PDF/cervical.pdf 2. Hoskins, WJ, Perez, CA, Young, RC, Barakat, RR, Markman, M, Randall, ME. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Willimas & Wilkins; Sedlis A, et al. A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study. Gynecologic Oncology. 1999;73(2):

6 DEVELOPMENT CREDITS This practice guideline is based on majority expert opinion of the Gynecologic Oncology Faculty at the University of Texas, M.D. Anderson Cancer Center. It was developed using a multidisciplinary approach that included input from the following medical oncologists, radiation oncologists, surgical oncologists, and interventional radiologists: Patricia Eifel, MD Ŧ Charles F. Levenback, MD Michael W. Bevers, MD Anuja Jhingran, MD Diane C. Bodrurka, MD Karen H. Lu, MD Thomas W. Burke, MD Pedro T. Ramirez, MD Robert L. Coleman, MD Lois M. Ramondetta, MD Ŧ Kathleen M. Schmeler, MD Anil K. Sood, MD, Ŧ Pamela T. Soliman, MD Judith K. Wolf, MD David M. Gershenson, MD Ann Klopp, MD Ŧ Michael Frumovitz, MD

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous

Invasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior

More information

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.

Gynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings. Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year

More information

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms

More information

Algorithms for management of Cervical cancer

Algorithms for management of Cervical cancer Algithms f management of Cervical cancer Algithms f management of cervical cancer are based on existing protocols and guidelines within the ESGO comunity and prepared by ESGO Educational Committe as a

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND

More information

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix

North of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April

More information

Chapter 8 Adenocarcinoma

Chapter 8 Adenocarcinoma Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted

More information

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review

More information

Role and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh

Role and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Role and Techniques of Surgery in Carcinoma Cervix Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Points for Discussion Pattern of spread Therapeutic options Types of surgical procedures

More information

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion 5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year

More information

CPC on Cervical Pathology

CPC on Cervical Pathology CPC on Cervical Pathology Dr. W.K. Ng Senior Medical Officer Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Cervical Smear: High Grade SIL (CIN III) Cervical Smear: High Grade

More information

Cervical cancer presentation

Cervical cancer presentation Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000

More information

Cervical Cancer Guidelines L and SC Network July Introduction:

Cervical Cancer Guidelines L and SC Network July Introduction: Cervical Cancer Guidelines L and SC Network July 2018 Introduction: There was a total number of 442 cases of cervix cancer diagnosed in Lancashire and South Cumbria Cancer Network in the period 2005 2009

More information

Guideline for the Management of Vulval Cancer

Guideline for the Management of Vulval Cancer Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11

More information

17 th ESO-ESMO Masterclass in clinical Oncology

17 th ESO-ESMO Masterclass in clinical Oncology 17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated

More information

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix. Uterine Cervix Protocol applies to all invasive carcinomas of the cervix. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition and FIGO 2001 Annual Report Procedures Cytology (No Accompanying

More information

Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer

Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer 대한부인종양콜포스코피학회제 24 차학술대회 Correlation of intermediate risk factors with prognostic factors in patients with early cervical cancer Seoul National University Bundang Hospital Eun Jung Soh, M.D. Cervical cancer

More information

Para-aortic laparoscopic lymph-node dissection for advanced cervical cancers

Para-aortic laparoscopic lymph-node dissection for advanced cervical cancers Para-aortic laparoscopic lymph-node dissection for advanced cervical cancers P. Mathevet, Hôpital Femme-Mère-Enfant, Bron Lymph-node involvement Is one of the major prognostic factor in gynecologic cancers.

More information

Staging and Treatment Update for Gynecologic Malignancies

Staging and Treatment Update for Gynecologic Malignancies Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths

More information

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

Adjuvant Therapies in Endometrial Cancer. Emma Hudson Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial

More information

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Vagina. 1. Introduction. 1.1 General Information and Aetiology Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.

More information

Management and Care of Women with Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline

Management and Care of Women with Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline Management and Care of Women with Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline www.asco.org/rs-cervical-cancer-treatment-guideline Introduction

More information

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial

Gynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial Gynecologic Cancer InterGroup Cervix Cancer Research Network The SHAPE Trial Comparing radical hysterectomy and pelvic node dissection against simple hysterectomy and pelvic node dissection in patients

More information

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB

MRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB MRI for cervical and endometrial cancers Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB RCR 06(1) RCR 06(1) Technique Pelvic multiphased-array coil Fasting? Buscopan? ABDOMEN!!! Cx:+/- HR

More information

MANAGEMENT OF CERVICAL CANCER

MANAGEMENT OF CERVICAL CANCER MANAGEMENT OF CERVICAL CANCER Dr. Ujeen Shrestha Malla* and Prof. Dr. Zhang Shui Rong Department of Obstetrics and Gynaecology, Clinical Medical College of Yangtze University, Jingzhou Central Hospital,

More information

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications Andres A. Roma, MD Cleveland Clinic No Disclosures In the past 12 months, I have not had

More information

Coversheet for Network Site Specific Group Agreed Documentation

Coversheet for Network Site Specific Group Agreed Documentation Coversheet for Network Site Specific Group Agreed Documentation This sheet is to accompany all documentation agreed by Pan Birmingham Cancer Network Site Specific Groups. This will assist the Network Governance

More information

Chapter 5 Stage III and IVa disease

Chapter 5 Stage III and IVa disease Page 55 Chapter 5 Stage III and IVa disease Overview Concurrent chemoradiotherapy (CCRT) is recommended for stage III and IVa disease. Recommended regimen for the chemotherapy portion generally include

More information

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with

More information

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines

Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology

More information

SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA

SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA Lead Grou p Log SLN Mapping in Cervical Cancer Nadeem R. Abu-Rustum, M.D. Memorial Sloan Kettering Cancer Center New York, USA Conflict of Interest Disclosure Nadeem R. Abu-Rustum, M.D. I have no financial

More information

Jacqui Morgan March 6, 2019

Jacqui Morgan March 6, 2019 Jacqui Morgan March 6, 2019 Case 1 25yo, G2P1 Here for WWE, no problems, healthy, needs refill on OCPs. Pap- Abnormal Glandular Cells-NOS Now What?? Case 1 Colposcopy What findings? Case 1 ECC Cervical

More information

Cervical Cancer: 2018 FIGO Staging

Cervical Cancer: 2018 FIGO Staging Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford

More information

ARROCase: Locally Advanced Endometrial Cancer

ARROCase: Locally Advanced Endometrial Cancer ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal

More information

MRI in Cervix and Endometrial Cancer

MRI in Cervix and Endometrial Cancer 28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial

More information

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center

Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy

More information

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008

A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator

More information

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data David Cibula Gynecologic Oncology Centre General University Hospital

More information

Prognostic significance of positive lymph node number in early cervical cancer

Prognostic significance of positive lymph node number in early cervical cancer 1052 Prognostic significance of positive lymph node number in early cervical cancer JUNG WOO PARK and JONG WOON BAE Department of Obstetrics and Gynecology, Dong A University Hospital, Dong A University

More information

Management and Care of Women with Invasive Cervical Cancer American Society of Clinical Oncology Resource-Stratified Clinical Practice Guidelines

Management and Care of Women with Invasive Cervical Cancer American Society of Clinical Oncology Resource-Stratified Clinical Practice Guidelines Management and Care of Women with Invasive Cervical Cancer American Society of Clinical Oncology Resource-Stratified Clinical Practice Guidelines www.asco.org/rs-cervical-cancer-treatment-guideline American

More information

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?

More information

Concurrent chemoradiation in treatment of carcinoma cervix

Concurrent chemoradiation in treatment of carcinoma cervix N. J. Obstet. Gynaecol Vol. 2, No. 1, p. 4-8 May -June 2007 REVIEW Concurrent chemoradiation in treatment of carcinoma cervix Meeta Singh, Rajshree Jha, Josie Baral, Suniti Rawal Dept of Obs/Gyn, TU Teaching

More information

Evolving Treatment Strategies for Cervical Cancer

Evolving Treatment Strategies for Cervical Cancer Evolving Treatment Strategies for Cervical Cancer Nadeem Abu-Rustum, MD Memorial Sloan Kettering Cancer Center Evolving Treatment Strategies 1. Surgery 2. Radiation 3. Chemotherapy Incidence of cervix

More information

Cervical Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version October 10, 2016 NCCN.org.

Cervical Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version October 10, 2016 NCCN.org. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 1.2017 October 10, 2016 NCCN.org Continue Version 1.2017, 10/10/16 National Comprehensive Cancer Network, Inc. 2016, All rights

More information

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Gynecologic Malignancies. Kristen D Starbuck 4/20/18 Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial

More information

of surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles

of surgical management of early invasive cervical cancer chapter Diagnosis and staging Wertheim described the principles chapter 14. Surgical management of early invasive cervical cancer CHAPTER 1 Wertheim described the principles of surgical management of invasive cervical cancer more than 100 years ago in his treatise

More information

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE.

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE. CARCINOMA CERVIX Dr. PREETHI REDDY. B M S OBG II yr POST GRADUATE. Introduction Cervical cancer is the second most common female malignancy worldwide. It is responsible for 4,66,000 deaths annually worldwide

More information

receive adjuvant chemotherapy

receive adjuvant chemotherapy Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer

More information

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)

ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic

More information

2016 Uterine Cancer Annual Report

2016 Uterine Cancer Annual Report 2016 Uterine Cancer Annual Report Overview At Carolinas HealthCare System s Levine Cancer Institute, we offer comprehensive care focused on using the latest technology and innovative techniques in the

More information

Cervical Cancer, Version

Cervical Cancer, Version NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Cervical Cancer, Version 3.2019 Wui-Jin Koh, MD/Chair 1,* ; Nadeem R. Abu-Rustum, MD 2,* ; Sarah Bean, MD 3 ; Kristin Bradley, MD 4 ; Susana M. Campos, MD,

More information

Role of Surgery in Cervical Cancer & Research Questions

Role of Surgery in Cervical Cancer & Research Questions Role of Surgery in Cervical Cancer & Research Questions Arb-aroon Lertkhachonsuk, M.D., Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Role of surgery in cervical cancer

More information

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States

More information

ORIGINAL PAPER. Department of Radiology, Nagoya University Graduate School of Medicine, Aichi, Japan 2

ORIGINAL PAPER. Department of Radiology, Nagoya University Graduate School of Medicine, Aichi, Japan 2 Nagoya J. Med. Sci. 79. 211 ~ 220, 2017 doi:10.18999/nagjms.79.2.211 ORIGINAL PAPER Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine

More information

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1

Gynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1 What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical

More information

Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer

Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Nicoletta Colombo, MD University of Milan-Bicocca European Institute of Oncology Milan, Italy NACT in Cervical Cancer NACT Stage -IB2 -IIA>4cm

More information

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT

More information

Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy

Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy SCIENTIFIC PAPER Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy Noah Rindos, MD, Christine L. Curry, MD, PhD, Rami Tabbarah, MD, Valena Wright, MD ABSTRACT Background and Objectives:

More information

Janjira Petsuksiri, M.D

Janjira Petsuksiri, M.D GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION

More information

Cervical Cancers Treatment Guideline KMHK

Cervical Cancers Treatment Guideline KMHK Cervical Cancers Treatment Guideline KMHK 子宮頸癌修訂紀錄 修訂日期修訂內容摘要 修訂頁次 版本 97 年 98 年 99 年 100 年 101 年 102 年 103 年 104 年 子宮頸癌診療指引新制訂新增子宮頸篩檢凖則多科會議討論檢視後未修改多科會議討論檢視後未修改多科會議討論檢視後未修改多科會議討論檢視後未修改 ;stage Ia1 做 simple

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive CANCER CERVIX Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive leison by PAP Smears. Etiology: Age - 2 peaks

More information

Cervical Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org. Continue

Cervical Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org. Continue NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 1.2015 NCCN.org Continue Version 1.2015, 08/07/14 National Comprehensive Cancer Network, Inc. 2014, All rights reserved. The NCCN

More information

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD The Role of Radiation in the Management of Gynecologic Cancers Scott Glaser, MD Nothing to disclose DISCLOSURE Outline The role of radiation in: Endometrial Cancer Adjuvant Medically inoperable Cervical

More information

A Review on Role of Human Papilomma Virus (HPV) In Cervical Cancer

A Review on Role of Human Papilomma Virus (HPV) In Cervical Cancer 21 Review Article A Review on Role of Human Papilomma Virus (HPV) In Cervical Cancer M.Sushma*, B.Vamsikrishna, M. Babu, R. Mohanraj Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical

More information

An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature

An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature Archives of Clinical and Medical Case Reports doi: 10.26502/acmcr.9655003 Volume 1, Issue 1 Case Report An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review

More information

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas) CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging

More information

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%

More information

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine

More information

Original Article. Introduction. Soyi Lim 1, Seok-Ho Lee 2, Kwang Beom Lee 1, Chan-Yong Park 1

Original Article. Introduction. Soyi Lim 1, Seok-Ho Lee 2, Kwang Beom Lee 1, Chan-Yong Park 1 Original Article Obstet Gynecol Sci 2016;59(3):184-191 http://dx.doi.org/10.5468/ogs.2016.59.3.184 pissn 2287-8572 eissn 2287-8580 The influence of number of high risk factors on clinical outcomes in patients

More information

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer Arch Gynecol Obstet (2012) 285:811 816 DOI 10.1007/s00404-011-2038-z GYNECOLOGIC ONCOLOGY Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical

More information

Enterprise Interest None

Enterprise Interest None Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf

More information

DEPARTMENT OF ONCOLOGY ELECTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:

More information

J Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION VOLUME 22 NUMBER 5 MARCH 1 2004 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical

More information

PROMISING TREATMENT RESULTS OF ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL HYSTERECTOMY FOR INTERMEDIATE RISK STAGE 1B CERVICAL CANCER

PROMISING TREATMENT RESULTS OF ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL HYSTERECTOMY FOR INTERMEDIATE RISK STAGE 1B CERVICAL CANCER ORIGINAL ARTICLE Obstet Gynecol Sci 2013;56(1):15-21 http://dx.doi.org/10.5468/ogs.2013.56.1.15 pissn 2287-8572 eissn 2287-8580 PROMISING TREATMENT RESULTS OF ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL HYSTERECTOMY

More information

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs

More information

University of Kentucky. Markey Cancer Center

University of Kentucky. Markey Cancer Center University of Kentucky Markey Cancer Center Invasive Cancer of the Vagina and Urethra Fred Ueland, MD No matter what you accomplish in your life, the size of your funeral will still be determined by the

More information

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department

More information

Endometrial Cancer. Incidence. Types 3/25/2019

Endometrial Cancer. Incidence. Types 3/25/2019 Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy

More information

Study of Rate of Hysterectomy in Patients with Cervical Cancer Referring to Radiotherapy and Oncology Ward of Ahvaz Golestan Hospital in

Study of Rate of Hysterectomy in Patients with Cervical Cancer Referring to Radiotherapy and Oncology Ward of Ahvaz Golestan Hospital in International Journal of Advanced Biotechnology and Research (IJBR) ISSN 0976-2612, Online ISSN 2278 599X, Vol-7, Special Issue-Number5-July, 2016, pp945-950 http://www.bipublication.com Research Article

More information

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media

ENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial

More information

RESEARCH ARTICLE. Kuanoon Boupaijit, Prapaporn Suprasert* Abstract. Introduction. Materials and Methods

RESEARCH ARTICLE. Kuanoon Boupaijit, Prapaporn Suprasert* Abstract. Introduction. Materials and Methods RESEARCH ARTICLE Survival Outcomes of Advanced and Recurrent Cervical Cancer Patients Treated with Chemotherapy: Experience of Northern Tertiary Care Hospital in Thailand Kuanoon Boupaijit, Prapaporn Suprasert*

More information

Cancer of the cervix uteri

Cancer of the cervix uteri DOI: 10.1002/ijgo.12611 FIGO CANCER REPORT 2018 Cancer of the cervix uteri Neerja Bhatla 1, * Daisuke Aoki 2 Daya Nand Sharma 3 Rengaswamy Sankaranarayanan 4 1 Department of Obstetrics and Gynecology,

More information

NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer V Continue.

NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer V Continue. Clinical in Oncology V.1.2007 Continue www.nccn.g TOC Panel Members * Benjamin E. Greer, MD/Chair Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance * Wui-Jin Koh, MD/Associate Chair Fred

More information

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:

More information

Vaginal intraepithelial neoplasia

Vaginal intraepithelial neoplasia Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the

More information

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป Brachytherapy การร กษาด วยร งส ระยะใกล Insertion การสอดใส แร Implantation การฝ งแร Surface application การวางแร physical benefit of brachytherapy - very high dose of radiation

More information

TOC NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence,

More information

Possibility of less radical treatment for patients with early invasive uterine cervical cancer

Possibility of less radical treatment for patients with early invasive uterine cervical cancer doi:10.1111/jog.12980 J. Obstet. Gynaecol. Res. Vol. 42, No. 7: 876 882, July 2016 Possibility of less radical treatment for patients with early invasive uterine cervical cancer Miseon Kim, Shinichi Ishioka,

More information

What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital

What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital Thai Journal of Obstetrics and Gynaecology April 2008, Vol. 16, pp. 79-8561-167 SPECIAL ARTICLE What We Have Learned from Over 1400 Radical Hysterectomy Operations in Chiang Mai University Hospital Jatupol

More information

The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer

The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer Original Article J Gynecol Oncol Vol. 25,. 2:9-96 http://dx.doi.org/.382/jgo.24.25.2.9 pissn 25-38 eissn 25-399 The relationship between positive peritoneal cytology and the prognosis of patients with

More information

CERVIX MEASURE SPECIFICATIONS

CERVIX MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve

More information

GCIG Cervix Committee: Chicago, USA May 30th Satoru Sagae (JGOG) Bradley Monk (GOG)

GCIG Cervix Committee: Chicago, USA May 30th Satoru Sagae (JGOG) Bradley Monk (GOG) GCIG Cervix Committee: Chicago, USA May 30th 2013 Satoru Sagae (JGOG) Bradley Monk (GOG) Conflict of Interest Disclosures CURRENT ACTIVE/NEAR ACTIVATION RANDOMIZED TRIALS WITH GCIG PARTICIPATION: Wellcome

More information

Patterns of Care in Patients with Cervical Cancer:

Patterns of Care in Patients with Cervical Cancer: Patterns of Care in Patients with Cervical Cancer: Power and Pitfalls of Claims-Based Analysis Grace Smith, MD, PhD, MPH Resident, PGY-5 Department of Radiation Oncology, MD Anderson Cancer Center Acknowledgments

More information

Hypofractionated RT in Cervix Cancer. Anuja Jhingran, MD

Hypofractionated RT in Cervix Cancer. Anuja Jhingran, MD Hypofractionated RT in Cervix Cancer Anuja Jhingran, MD Hypofractionated RT in Cervix Cancer: Clinicaltrials.gov 919 cervix trials 134 hypofractionated RT trials Prostate, breast, NSCLC, GBM 0 cervix trials

More information

https://patient.varian.com/sit es/default/files/videos/origin al/imrt.mp4 brachy- from Greek brakhys "short" Historically LDR has been used. Cs-137 at 0.4-0.8 Gy/h With optimally placed device, dose

More information

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy Case Report Obstet Gynecol Sci 2014;57(6):539-543 http://dx.doi.org/10.5468/ogs.2014.57.6.539 pissn 2287-8572 eissn 2287-8580 Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for

More information

RESEARCH ARTICLE. Abstract. Introduction. Materials and Methods

RESEARCH ARTICLE. Abstract. Introduction. Materials and Methods DOI:http://dx.doi.org/10.7314/APJCP.2015.16.14.5951 Pathologic Risk Factors and Outcomes of Early-Stage Cervical Carcinoma RESEARCH ARTICLE Pathologic Risk Factors and Oncologic Outcomes in Early-stage

More information

Locally advanced disease & challenges in management

Locally advanced disease & challenges in management Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden

More information